Volume | 646,787 |
|
|||||
News | - | ||||||
Day High | 0.709 | Low High |
|||||
Day Low | 0.6603 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Vaxart Inc | VXRT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.6985 | 0.6603 | 0.709 | 0.6584 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
1,606 | 646,787 | $ 0.6829813 | $ 441,743 | - | 0.53 - 1.59 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
12:06:32 | 2 | $ 0.67755 | USD |
Vaxart Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
114.75M | 173.86M | - | 7.38M | -82.47M | -0.47 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Vaxart News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VXRT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.82 | 0.8568 | 0.6331 | 0.7218726 | 1,560,934 | -0.14245 | -17.37% |
1 Month | 1.33 | 1.34 | 0.6331 | 0.9709773 | 1,657,447 | -0.65245 | -49.06% |
3 Months | 1.20 | 1.54 | 0.6331 | 1.15 | 1,721,431 | -0.52245 | -43.54% |
6 Months | 0.6341 | 1.54 | 0.53 | 0.9854986 | 1,510,529 | 0.04345 | 6.85% |
1 Year | 0.73 | 1.59 | 0.53 | 0.9514277 | 1,555,231 | -0.05245 | -7.18% |
3 Years | 5.68 | 11.108 | 0.53 | 5.76 | 4,002,974 | -5.00 | -88.07% |
5 Years | 0.6816 | 24.90 | 0.2543 | 6.72 | 6,435,825 | -0.00405 | -0.59% |
Vaxart Description
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States. |